Orchestra BioMed Holdings (OBIO) EBT Margin Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -2,817.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1,558.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -683.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 2,688.00
10 Orchestra BioMed Holdings 245.24 Mn 255.02 Mn 78,000.00 -1.87 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.87 Mn
Dec 31, 2025 640,475.00
Sep 30, 2025 -85,613.00
Jun 30, 2025 -26,512.00
Mar 31, 2025 171.00
Dec 31, 2024 -204,454.00
Sep 30, 2024 168,505.00
Jun 30, 2024 -63,507.00
Mar 31, 2024 -117,058.00
Dec 31, 2023 -344,982.00
Sep 30, 2023 -238,237.00
Jun 30, 2023 48,778.00
Mar 31, 2023 -39,969.00